Search

everythinglearnresearchcommunity

for

Search:↓

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Genetic data can predict male-pattern baldness with moderate accuracy, especially for early-onset cases in some European men.

Female hair loss linked to metabolic syndrome, not in males.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

SJS/TEN survivors often have severe, overlooked long-term physical problems that are not properly treated after leaving the hospital.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

Sex hormones affect brain injury differently in males and females.

Finasteride reduces new brain cells in male mice, possibly causing depression.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Diagnosing PCOS in teenagers is hard because its symptoms often look like normal puberty, and there's a need for better diagnosis methods and agreement on criteria.

Recent genetic insights show that low-renin hypertension includes a range from essential hypertension to secondary or familial forms, affecting diagnosis and treatment.

South Asian women with PCOS present with different symptoms compared to White women, influenced by ethnicity, obesity, and age.

Rats had lasting erectile problems after stopping a certain medication.

New compounds were found to help increase hair growth and decrease hair loss.

Autoimmune liver diseases are likely linked to certain skin conditions like vitiligo and psoriasis.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.

Gilles de la Tourette syndrome is treatable, with behavioral therapy as a recommended first option and other treatments available for more severe cases.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

Most men with hair loss worry, try self-treatments, and delay doctor visits due to cost, uncertainty, and embarrassment.